Patents Represented by Attorney, Agent or Law Firm Incyte Genomics
-
Patent number: 6313266Abstract: The invention provides a human nucleolin-like protein (HNLP) and polynucleotides which identify and encode HNLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HNLP.Type: GrantFiled: February 1, 1999Date of Patent: November 6, 2001Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Henry Yue, Neil C. Corley, Purvi Shah
-
Patent number: 6309821Abstract: The present invention provides nucleotide and amino acid sequences for a novel PAC10 human homolog. The present invention also provides for antisense molecules, diagnostic molecules, genetically engineered expression vectors and host cells for the production of purified PAC10 homologs; antibodies, agonists, antagonists and inhibitors of the PAC10 human homolog; and pharmaceutical compositions and methods of treatment based on the polypeptide, its antibodies, ntagonists and inhibitors. The invention further provides diagnostic and theapeutic compositions for the detection and treatment of X-linked congenital abnormalities, such as centronuclear myopathy.Type: GrantFiled: May 16, 1996Date of Patent: October 30, 2001Assignee: Incyte Genomics, Inc.Inventors: Janice Au-Young, Richard D. Goold
-
Patent number: 6309637Abstract: The invention provides a human microfibril-associated glycoprotein 4 splice variant (MAG4V) and polynucleotides which identify and encode MAG4V. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of MAG4V.Type: GrantFiled: December 21, 1999Date of Patent: October 30, 2001Assignee: Incyte Genomics, Inc.Inventors: Y. Tom Tang, Neil C. Corley, Purvi Shah
-
Patent number: 6307021Abstract: The present invention provides a human apoptosis regulator protein (APRG) and polynucleotides which identify and encode APRG. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding APRG and a method for producing APRG. The invention also provides for agonists, antibodies, or antagonists specifically binding APRG, and their use, in the prevention and treatment of diseases associated with expression of APRG. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding APRG for the treatment of diseases associated with the expression of APRG. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding APRG.Type: GrantFiled: November 24, 1998Date of Patent: October 23, 2001Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli, Jennifer L. Hillman
-
Patent number: 6303765Abstract: The invention provides two human extracellular matrix proteins (ECMP) and polynucleotides which identify and encode ECMP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of ECMP.Type: GrantFiled: December 15, 1998Date of Patent: October 16, 2001Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Neil C. Corley, Karl J. Guegler
-
Patent number: 6300472Abstract: The invention provides three human Rab proteins (RABP) and polynucleotides which identify and encode RABP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of RABP.Type: GrantFiled: September 16, 1998Date of Patent: October 9, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah
-
Patent number: 6287786Abstract: The invention provides a mammalian nucleic acid molecule and fragments thereof. It also provides for the use of the nucleic acid molecule for the characterization, diagnosis, or treatment of conditions, diseases and disorders associated with gene expression and for the production of a model system. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid molecule.Type: GrantFiled: July 31, 2000Date of Patent: September 11, 2001Assignee: Incyte Genomics, Inc.Inventors: Matthew R. Kaser, Jennifer L. Hillman, Mariah R. Baughn
-
Patent number: 6280733Abstract: The present invention provides a human microtubule-associated protein (hLC3) and the polynucleotides which identify and encode hLC3. The invention also provides genetically engineered expression vectors, host cells, and a method for producing hLC3. The invention also provides hLC3 as well as agonists, antibodies, and antagonists of hLC3, and the use thereof for the prevention and treatment of diseases associated with the expression of hLC3. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding hLC3 for the treatment of diseases associated with the expression of hLC3. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding hLC3.Type: GrantFiled: November 24, 1998Date of Patent: August 28, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Surya K. Goli
-
Patent number: 6281190Abstract: The present invention provides a human LEA motif protein (HuLEAP) and polynucleotides which identify and encode HuLEAP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HuLEAP and a method for producing HuLEAP. The invention also provides for agonists, antibodies, or antagonists specifically binding HuLEAP, and their use, in the prevention and treatment of diseases associated with expression of HuLEAP. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HuLEAP for the treatment of diseases associated with the expression of HuLEAP. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HuLEAP.Type: GrantFiled: December 15, 1998Date of Patent: August 28, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Surya K. Goli
-
Patent number: 6281334Abstract: The invention provides three human proteins associated with cell proliferation, referred to collectively as “APOP” and individually as “APOP-1”, “APOP-2”, and “APOP-3”, and polynucleotides which identify and encode APOP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for preventing and treating disorders associated with expression of APOP.Type: GrantFiled: September 30, 1999Date of Patent: August 28, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Henry Yue, Pretti Lal, Purvi Shah, Neil C. Corley
-
Patent number: 6281333Abstract: The present invention provides a polynucleotide which identifies and encodes a novel human galectin-8. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding human galectin-8. The invention also provides for the production and use of substantially purified human galectin-8 in pharmaceutical compositions to increase immune responses. The invention also provides for the use of antisense molecules and antibodies in pharmaceutical compositions to decrease immune response. The invention also describes diagnostic assays which utilize the polynucleotide to hybridize with the transcripts and/or genomic DNA encoding human galectin-8 and anti-human galectin-8 antibodies which specifically bind to human galectin-8.Type: GrantFiled: December 15, 1998Date of Patent: August 28, 2001Assignee: Incyte Genomics, Inc.Inventors: Phillip R. Hawkins, Olga Bandman
-
Patent number: 6277568Abstract: The invention provides human ubiquitin-conjugating enzyme homologs (UCEH) and polynucleotides which identify and encode UCEH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists.Type: GrantFiled: April 9, 1998Date of Patent: August 21, 2001Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Mariah Baughn, Yalda Azimzai
-
Patent number: 6277373Abstract: The invention provides a human phosphatidylinositol 4,5-bisphosphate 5-phosphatase (PBPP) and polynucleotides which identify and encode PBPP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PBPP.Type: GrantFiled: February 26, 1999Date of Patent: August 21, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah
-
Patent number: 6277574Abstract: The invention provides novel kidney disease-associated genes and polypeptides encoded by those genes. The invention also provides expression vectors, host cells, and antibodies. The invention also provides methods for diagnosing, treating or preventing diseases of the kidney.Type: GrantFiled: April 9, 1999Date of Patent: August 21, 2001Assignee: Incyte Genomics, Inc.Inventors: Michael G. Walker, Wayne Volkmuth, Tod M. Klingler, Yalda Azimzai, Henry Yue
-
Patent number: 6277377Abstract: The invention provides a new human phosphodiesterase regulatory subunit (HPRS) and polynucleotides which encode HPRS. The invention also provides expression vectors, host cells, agonists, the complement of the polynucleotide sequence and antibodies. The invention also provides methods for treating disorders associated with expression of HPRS.Type: GrantFiled: February 22, 1999Date of Patent: August 21, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
-
Patent number: 6274720Abstract: The invention provides a human preproneurotensin/neuromedin N (HPPN) and polynucleotides which identify and encode HPPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HPPN.Type: GrantFiled: December 31, 1997Date of Patent: August 14, 2001Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Purvi Shah, Neil C. Corley
-
Patent number: 6274138Abstract: The invention provides a human mitochondrial malate dehydrogenase (MT-MDH) and polynucleotides which identify and encode MT-MDH. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of MT-MDH.Type: GrantFiled: September 3, 1997Date of Patent: August 14, 2001Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Neil C. Corley, Purvi Shah
-
Patent number: 6268164Abstract: The invention provides a human goose-type lysozyme (GOLY) and polynucleotides which identify and encode GOLY. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GOLY.Type: GrantFiled: February 23, 2000Date of Patent: July 31, 2001Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson
-
Patent number: 6268192Abstract: The invention provides a human delta 1-pyrroline-5-carboxylate reductase homolog (P5CRH) and polynucleotides which identify and encode P5CRH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of P5CRH.Type: GrantFiled: May 5, 2000Date of Patent: July 31, 2001Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Neil C. Corley, Mariah R. Baughn
-
Patent number: 6265565Abstract: The invention provides a human prostate associated Ets protein (PRAEP) and polynucleotides which identify and encode PRAEP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PRAEP.Type: GrantFiled: April 3, 1998Date of Patent: July 24, 2001Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Karl J. Guegler, Preeti Lal, Neil C. Corley